90 Novel approach for childhood Sjögren’s Disease therapies: multistakeholder design of a series of N-of-1 trials
OBJECTIVES/GOALS: Childhood Sjögren’s disease (cSD) is a rare autoimmune disease. Despite the profound impact on children and their families, pediatric-specific clinical trials to inform therapeutic strategies in cSD are lacking. In 2022 we participated in the Trial Innovation Network (TIN) Design L...
Main Authors: | Nora G. Singer, Sara M Stern, Marisha E Palm, Harry Selker, Ludovic Trinquart |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2024-04-01
|
Series: | Journal of Clinical and Translational Science |
Online Access: | https://www.cambridge.org/core/product/identifier/S2059866124000888/type/journal_article |
Similar Items
-
The use of N-of-1 trials to generate real-world evidence for optimal treatment of individuals and populations
by: Harry P. Selker, et al.
Published: (2023-01-01) -
From a decentralized clinical trial to a decentralized and clinical-trial-in-a-box platform: Towards patient-centric and equitable trials
by: Dorothy Dulko, et al.
Published: (2023-01-01) -
555 Design Lab Methodology Supports Innovation in Clinical Trials
by: Marisha E Palm, et al.
Published: (2024-04-01) -
Sharing data among clinical trials of therapeutics in COVID-19: Barriers and facilitators to collaborating in a crisis
by: Marisha E. Palm, et al.
Published: (2022-01-01) -
Commercial diplomacy and multistakeholder diplomacy
by: Л. Кужмова
Published: (2016-04-01)